Table 10.1GRADE profile: Does the length of time before empiric antibiotics are given influence patient outcomes?

Quality assessmentNo of patientsEffectQuality
No of studyDesignLimitationsInconsistencyIndirectnessImprecisionOther considerationsNon-delayed antibiotic therapyDelayed antibiotic therapyRelative
(95% CI)
Absolute
Short term mortality: in cancer patients with septic shock 1
1observational studyserious2no serious inconsistencyserious3no serious imprecisionnone18/20 (90%)39/68 (57.4%)OR 6.5 (1.39 to 30.49)324 more per 1000 (from 78 more to 403 more)VERY LOW
Short-term mortality: in patients with bacreremia (67/1523 (4.4%) had ANC < 500 )
1observational studyserious2no serious inconsistencyserious4very seriousstrong association79/983 (8%)50/540 (9.3%)OR 0.85 (0.59 to 1.24)-93 fewer per 1000 (from 93 fewer to 93 fewer)VERY LOW
Short-term mortality: in non-ICU patients with bacteremia and ANC < 100
1observational studyserious2no serious inconsistencyserious5very serious6strong associationNot reportedNot reportedOR 18 (2.84 to 113.5)Not calculableVERY LOW
Short-term mortality: in non-ICU patients with bacteremia and ANC 100-500
1observational studyserious2no serious inconsistencyvery serious5,7very serious6noneNot reportedNot reportedOR 1.92 (0.17 to 21.6)Not calculableVERY LOW
Short-term mortality: in non-ICU patients with bacteremia and ANC > 500
1observational studyserious2no serious inconsistencyvery serious5,8very serious6noneNot reportedNot reportedOR 1.78 (0.91 to 3.45)Not calculableVERY LOW
Short-term mortality: in ICU patients with bacteremia and ANC < 100
1observational studyserious2no serious inconsistencyserious5very serious6noneNot reportedNot reportedOR 5.56 (0.85 to 36.3)Not calculableVERY LOW
Short-term mortality: in ICU patients with bacteremia and ANC 100-500
1observational studyserious2no serious inconsistencyvery serious5,7very serious6noneNot reportedNot reportedOR 0.59 (0.06 to 6.22)Not calculableVERY LOW
Short-term mortality: in ICU patients with bacteremia and ANC > 500
1observational studyserious2no serious inconsistencyvery serious5,8very serious6noneNot reportedNot reportedOR 0.55 (0.29 to 1.02)Not calculableVERY LOW
1

Mortality was not reported by group. These figures were calculated from the overall mortality rate and the odds ratio

2

Observational study

3

Cancer patients with septic shock. Very high mortality rate.

4

Patients with bacteremia (not all neutropenic)

5

Patients with bacteremia

6

Very small number of events

7

Patients with ANC 100-500

From: Initial Treatment: guideline chapter six

Cover of Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients
Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.
NICE Clinical Guidelines, No. 151.
National Collaborating Centre for Cancer (UK).
Copyright © National Collaborating Centre for Cancer, 2012.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.